Items where Author is "Khamesipour, A."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 16.

Article

Jaafari, M. R. and Hatamipour, M. and Alavizadeh, S. H. and Abbasi, A. and Saberi, Z. and Rafati, S. and Taslimi, Y. and Mohammadi, A. M. and Khamesipour, A. (2019) Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis. International Journal for Parasitology: Drugs and Drug Resistance, 11. pp. 156-165.

Molkara, S. and Poursoltani, E. and Stahl, K. W. and Maleki, M. and Khamesipour, A. and Bogdan, C. and Salehi, M. and Goyonlo, V. M. (2019) Salvage therapy with Sodium chlorosum (formerly DAC N-055) for cases of refractory lupoid cutaneous leishmaniasis: Results from a compassionate use study with 0.09 Sodium chlorosum in amphiphilic basic cream. BMC Infectious Diseases, 19 (1).

Olliaro, P. and Grogl, M. and Boni, M. and Carvalho, E. M. and Chebli, H. and Cisse, M. and Diro, E. and Fernandes Cota, G. and Erber, A. C. and Gadisa, E. and Handjani, F. and Khamesipour, A. and Llanos-Cuentas, A. and López Carvajal, L. and Grout, L. and Lmimouni, B. E. and Mokni, M. and Nahzat, M. S. and Ben Salah, A. and Ozbel, Y. and Pascale, J. M. and Rizzo Molina, N. and Rode, J. and Romero, G. and Ruiz-Postigo, J. A. and Gore Saravia, N. and Soto, J. and Uzun, S. and Mashayekhi, V. and Vélez, I. D. and Vogt, F. and Zerpa, O. and Arana, B. (2018) Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation. PLoS Neglected Tropical Diseases, 12 (1).

Emami, T. and Rezayat, S. M. and Khamesipour, A. and Madani, R. and Habibi, G. and Hojatizade, M. and Jaafari, M. R. (2018) The role of MPL and imiquimod adjuvants in enhancement of immune response and protection in BALB/c mice immunized with soluble Leishmania antigen (SLA) encapsulated in nanoliposome. Artificial Cells, Nanomedicine and Biotechnology, 46 (sup2). pp. 324-333.

Naseri, H. and Eskandari, F. and Jaafari, M. R. and Khamesipour, A. and Abbasi, A. and Badiee, A. (2017) PEGylation of cationic liposomes encapsulating soluble Leishmania antigens reduces the adjuvant efficacy of liposomes in murine model. Parasite Immunology, 39 (11).

Mobasheri, M. and Attar, H. and Sorkhabadi, S. M. R. and Khamesipour, A. and Jaafari, M. R. (2016) Solubilization behavior of polyene antibiotics in nanomicellar system: Insights from molecular dynamics simulation of the amphotericin B and Nystatin interactions with polysorbate 80. Molecules, 21 (1).

Shargh, V. H. and Jaafari, M. R. and Khamesipour, A. and Jaafari, I. and Jalali, S. A. and Abbasi, A. and Badiee, A. (2012) Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis. Vaccine, 30 (26). pp. 3957-3964.

Khamesipour, A. and Abbasi, A. and Firooz, A. and Amin Mohammadi, A. M. and Eskandari, S. E. and Jaafari, M. R. (2012) Treatment of cutaneous lesion of 20 years' duration caused by leishmanization. Indian Journal of Dermatology, 57 (2). pp. 123-125.

Tafaghodi, M. and Eskandari, M. and Khamesipour, A. and Jaafari, M. R. (2011) Alginate microspheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis. Experimental Parasitology, 129 (2). pp. 107-114.

Tafaghodi, M. and Eskandari, M. and Khamesipour, A. and Jaafari, M. R. (2011) Alginate microspheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis. Experimental Parasitology, 129 (2). pp. 107-114.

Tafaghodi, M. and Khamesipour, A. and Jaafari, M. R. (2011) Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN. Parasitology Research, 108 (5). pp. 1265-1273.

Tafaghodi, M. and Khamesipour, A. and Jaafari, M. R. (2011) Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN. Parasitology Research, 108 (5). pp. 1265-1273.

Tafaghodi, M. and Eskandari, M. and Kharazizadeh, M. and Khamesipour, A. and Jaafari, M. R. (2010) Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins. Tropical Biomedicine, 27 (3). pp. 639-650.

Tafaghodi, M. and Eskandari, M. and Kharazizadeh, M. and Khamesipour, A. and Jaafari, M. R. (2010) Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins. Tropical Biomedicine, 27 (3). pp. 639-650.

Badiee, A. and Jaafari, M. R. and Samiei, A. and Soroush, D. and Khamesipour, A. (2008) Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c mice. Clinical and Vaccine Immunology, 15 (4). pp. 668-674.

Firooz, A. and Khamesipour, A. and Ghoorchi, M. H. and Nassiri-Kashani, M. and Eskandari, S. E. and Khatami, A. and Hooshmand, B. and Gorouhi, F. and Rashighi-Firoozabadi, M. and Dowlati, Y. (2006) Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: A randomized assessor-blind controlled trial. Archives of Dermatology, 142 (12). pp. 1575-1579.

This list was generated on Tue Aug 4 19:28:05 2020 EDT.